Cargando…
Differential Diagnosis of Hyperferritinemia in Critically Ill Patients
Background: Elevated serum ferritin is a common condition in critically ill patients. It is well known that hyperferritinemia constitutes a good biomarker for hemophagocytic lymphohistiocytosis (HLH) in critically ill patients. However, further differential diagnoses of hyperferritinemia in adult cr...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821140/ https://www.ncbi.nlm.nih.gov/pubmed/36614993 http://dx.doi.org/10.3390/jcm12010192 |
_version_ | 1784865626428276736 |
---|---|
author | Schuster, Friederike S. Nyvlt, Peter Heeren, Patrick Spies, Claudia Adam, Moritz F. Schenk, Thomas Brunkhorst, Frank M. Janka, Gritta La Rosée, Paul Lachmann, Cornelia Lachmann, Gunnar |
author_facet | Schuster, Friederike S. Nyvlt, Peter Heeren, Patrick Spies, Claudia Adam, Moritz F. Schenk, Thomas Brunkhorst, Frank M. Janka, Gritta La Rosée, Paul Lachmann, Cornelia Lachmann, Gunnar |
author_sort | Schuster, Friederike S. |
collection | PubMed |
description | Background: Elevated serum ferritin is a common condition in critically ill patients. It is well known that hyperferritinemia constitutes a good biomarker for hemophagocytic lymphohistiocytosis (HLH) in critically ill patients. However, further differential diagnoses of hyperferritinemia in adult critically ill patients remain poorly investigated. We sought to systematically investigate hyperferritinemia in adult critically ill patients without HLH. Methods: In this secondary analysis of a retrospective observational study, patients ≥18 years admitted to at least one adult intensive care unit at Charité–Universitätsmedizin Berlin between January 2006 and August 2018, and with hyperferritinemia of ≥500 μg/L were included. Patients with HLH were excluded. All patients were categorized into non-sepsis, sepsis, and septic shock. They were also classified into 17 disease groups, based on their ICD-10 codes, and pre-existing immunosuppression was determined. Uni- and multivariable linear regression analyses were performed in all patients. Results: A total of 2583 patients were analyzed. Multivariable linear regression analysis revealed positive associations of maximum SOFA score, sepsis or septic shock, liver disease (except hepatitis), and hematological malignancy with maximum ferritin. T/NK cell lymphoma, acute myeloblastic leukemia, Kaposi’s sarcoma, acute or subacute liver failure, and hepatic veno-occlusive disease were positively associated with maximum ferritin in post-hoc multivariable linear regression analysis. Conclusions: Sepsis or septic shock, liver disease (except hepatitis) and hematological malignancy are important differential diagnoses in hyperferritinemic adult critically ill patients without HLH. Together with HLH, they complete the quartet of important differential diagnoses of hyperferritinemia in adult critically ill patients. As these conditions are also related to HLH, it is important to apply HLH-2004 criteria for exclusion of HLH in hyperferritinemic patients. Hyperferritinemic critically ill patients without HLH require quick investigation of differential diagnoses. |
format | Online Article Text |
id | pubmed-9821140 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98211402023-01-07 Differential Diagnosis of Hyperferritinemia in Critically Ill Patients Schuster, Friederike S. Nyvlt, Peter Heeren, Patrick Spies, Claudia Adam, Moritz F. Schenk, Thomas Brunkhorst, Frank M. Janka, Gritta La Rosée, Paul Lachmann, Cornelia Lachmann, Gunnar J Clin Med Article Background: Elevated serum ferritin is a common condition in critically ill patients. It is well known that hyperferritinemia constitutes a good biomarker for hemophagocytic lymphohistiocytosis (HLH) in critically ill patients. However, further differential diagnoses of hyperferritinemia in adult critically ill patients remain poorly investigated. We sought to systematically investigate hyperferritinemia in adult critically ill patients without HLH. Methods: In this secondary analysis of a retrospective observational study, patients ≥18 years admitted to at least one adult intensive care unit at Charité–Universitätsmedizin Berlin between January 2006 and August 2018, and with hyperferritinemia of ≥500 μg/L were included. Patients with HLH were excluded. All patients were categorized into non-sepsis, sepsis, and septic shock. They were also classified into 17 disease groups, based on their ICD-10 codes, and pre-existing immunosuppression was determined. Uni- and multivariable linear regression analyses were performed in all patients. Results: A total of 2583 patients were analyzed. Multivariable linear regression analysis revealed positive associations of maximum SOFA score, sepsis or septic shock, liver disease (except hepatitis), and hematological malignancy with maximum ferritin. T/NK cell lymphoma, acute myeloblastic leukemia, Kaposi’s sarcoma, acute or subacute liver failure, and hepatic veno-occlusive disease were positively associated with maximum ferritin in post-hoc multivariable linear regression analysis. Conclusions: Sepsis or septic shock, liver disease (except hepatitis) and hematological malignancy are important differential diagnoses in hyperferritinemic adult critically ill patients without HLH. Together with HLH, they complete the quartet of important differential diagnoses of hyperferritinemia in adult critically ill patients. As these conditions are also related to HLH, it is important to apply HLH-2004 criteria for exclusion of HLH in hyperferritinemic patients. Hyperferritinemic critically ill patients without HLH require quick investigation of differential diagnoses. MDPI 2022-12-27 /pmc/articles/PMC9821140/ /pubmed/36614993 http://dx.doi.org/10.3390/jcm12010192 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Schuster, Friederike S. Nyvlt, Peter Heeren, Patrick Spies, Claudia Adam, Moritz F. Schenk, Thomas Brunkhorst, Frank M. Janka, Gritta La Rosée, Paul Lachmann, Cornelia Lachmann, Gunnar Differential Diagnosis of Hyperferritinemia in Critically Ill Patients |
title | Differential Diagnosis of Hyperferritinemia in Critically Ill Patients |
title_full | Differential Diagnosis of Hyperferritinemia in Critically Ill Patients |
title_fullStr | Differential Diagnosis of Hyperferritinemia in Critically Ill Patients |
title_full_unstemmed | Differential Diagnosis of Hyperferritinemia in Critically Ill Patients |
title_short | Differential Diagnosis of Hyperferritinemia in Critically Ill Patients |
title_sort | differential diagnosis of hyperferritinemia in critically ill patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821140/ https://www.ncbi.nlm.nih.gov/pubmed/36614993 http://dx.doi.org/10.3390/jcm12010192 |
work_keys_str_mv | AT schusterfriederikes differentialdiagnosisofhyperferritinemiaincriticallyillpatients AT nyvltpeter differentialdiagnosisofhyperferritinemiaincriticallyillpatients AT heerenpatrick differentialdiagnosisofhyperferritinemiaincriticallyillpatients AT spiesclaudia differentialdiagnosisofhyperferritinemiaincriticallyillpatients AT adammoritzf differentialdiagnosisofhyperferritinemiaincriticallyillpatients AT schenkthomas differentialdiagnosisofhyperferritinemiaincriticallyillpatients AT brunkhorstfrankm differentialdiagnosisofhyperferritinemiaincriticallyillpatients AT jankagritta differentialdiagnosisofhyperferritinemiaincriticallyillpatients AT laroseepaul differentialdiagnosisofhyperferritinemiaincriticallyillpatients AT lachmanncornelia differentialdiagnosisofhyperferritinemiaincriticallyillpatients AT lachmanngunnar differentialdiagnosisofhyperferritinemiaincriticallyillpatients |